Speedy trial platform aims to find best COVID-19 drugs

NCT ID NCT04746183

Recruiting now Disease control Sponsor: University of Liverpool Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests several potential COVID-19 treatments in adults to find safe doses and see if they help patients recover faster. It uses a flexible 'platform' design to add new drugs quickly. The trial includes people with mild to severe COVID-19 and focuses on reducing symptoms and preventing serious complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19

Contacts and locations

Locations

Desmond Tutu Health Foundation
COMPLETED

Cape Town, South Africa
Ezintsha
COMPLETED

Johannesburg, South Africa
Kings College Hospital NHS Foundation Trust
ACTIVE_NOT_RECRUITING

London, United Kingdom
Liverpool University Hospitals NHS Foundation Trust
RECRUITING

Liverpool, L7 8XP, United Kingdom
Manchester University NHS Foundation Trust
RECRUITING

Manchester, United Kingdom
Royal Free Hospital
RECRUITING

London, United Kingdom
University Hospital Southampton NHS Foundation Trust
RECRUITING

Southampton, SO16 6YD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.